ロード中...
Antiglutamate Receptor Antibodies and Cognitive Impairment in Primary Antiphospholipid Syndrome and Systemic Lupus Erythematosus
Systemic lupus erythematosus (SLE) and antiphospholipid syndrome have an increased risk to develop cognitive impairment. A possible role for antiphospholipid antibodies (aPL) and antiglutamate receptor (anti-NMDA) antibodies in the pathogenesis of neurological manifestations of these two conditions,...
保存先:
| 出版年: | Front Immunol |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4740786/ https://ncbi.nlm.nih.gov/pubmed/26870034 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2016.00005 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|